Gossamer Bio, Inc. (GOSS)
Last updated: 2026-10-21 19:29:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Gossamer Bio, Inc. (GOSS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $9.86, with a market capitalization of $51.56M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.29 to $309.60. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$51.56M | |
$9.50 | |
$2,171.98 | |
$8.29 | |
$9.58 | |
191.53K | |
375.99K | |
-- | |
$309.60 | |
$8.29 | |
-- | |
-- |
Gossamer Bio, Inc. (GOSS) Stock Price Today
Gossamer Bio, Inc. (GOSS) is currently trading at $9.86 as of 2026-10-21 19:26:00, up 2.93% ($0.28) from the previous close of $9.58
During today's regular trading session, GOSS has traded between $8.29 and $2,171.98, with a trading volume of 191.53K shares. The current price is near the lower end of today's range.
Gossamer Bio, Inc. (GOSS) 7-Day Stock Price Change
Over the past seven days, Gossamer Bio, Inc. (GOSS) moved from $9.28 to $9.86, representing a gain of 6.26% ($0.58).
The stock traded between $8.29 and $10.38 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 251.37 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
GOSS 52-Week Price Position
Position in Range: 0.5%
GOSS is currently trading at $9.86, placing it 0.5% of the way from its 52-week low of $8.29 to its 52-week high of $309.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Gossamer Bio, Inc. (GOSS)?
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Gossamer Bio, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 162 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Gossamer Bio, Inc. (GOSS) Stock on MEXC
Eligible investors can buy real shares of Gossamer Bio, Inc. (GOSS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Gossamer Bio, Inc. (GOSS) stock price today?
2.Is GOSS stock going up or down today?
3.What is GOSS pre-market price?
4.What is GOSS after-hours price?
5.Is GOSS stock trading now?
6.Where does GOSS sit relative to its 52-week high and low?
7.What sector is Gossamer Bio, Inc. in?
8.What is Gossamer Bio, Inc.'s market capitalization and where is it listed?
9.How is GOSS valued in terms of P/E ratio and EPS?
10.Does Gossamer Bio, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
GOSS Stock Calculator
Estimate the value between GOSS shares and USD.
GOSS Shares to USD
1.00 GOSS shares = 9.861 USD
Calculations are estimates based on the latest available price and are for reference only.


